Navneet Majhail, MD, MS, FASTCT
Physician-in-Chief of Blood Cancers, Sarah Cannon Cancer Institute
Dr. Majhail leads the Sarah Cannon Transplant & Cellular Therapy Network which provides a multidisciplinary approach to the treatment of blood cancers and offers increased access to cutting-edge cell and transplant therapies.
Prior to his time with Sarah Cannon, he served as the director of the Cleveland Clinic’s blood and marrow transplant program while also serving as the vice chair for the department of hematology and medical oncology and a professor of medicine with the Cleveland Clinic Lerner College of Medicine. He is a past-president of the American Society for Transplantation and Cellular Therapy (ASTCT) and has been recognized as a fellow for his contributions to the field of transplantation and cellular therapy. He is a respected thought leader in health outcomes research and has published extensively on the prevention and management of early and late complications of hematopoietic cell transplantation and health policy issues such as healthcare disparities, quality of care, survivorship and economic issues related to transplantation and cellular therapy.
In addition to his work at Sarah Cannon, Dr. Majhail serves as program medical director for the Sarah Cannon Transplant & Cellular Therapy Program at TriStar Centennial Medical Center in Nashville, Tenn.